8 results match your criteria: "Fundación Privada Hospital de Mollet[Affiliation]"
J Antimicrob Chemother
October 2017
Complexo Hospitalario Universitario de Vigo, IIS Galicia Sur, España.
Background: New direct-acting antiviral agents (DAAs) have shown great efficacy and tolerability in clinical trials and real-life cohorts. However, data are scarce regarding efficacy and safety in cirrhotic HCV/HIV-coinfected patients.
Methods: A multicentre prospective analysis was performed in 13 Spanish hospitals, including all cirrhotic HCV/HIV-coinfected patients starting DAA combinations from January to December 2015.
Clin Appl Thromb Hemost
October 2017
11 Department of Internal Medicine, Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain.
Background: The outcome of patients with upper extremity deep vein thrombosis (UEDVT) has not been consistently compared with that in patients with lower extremity deep vein thrombosis (LEDVT).
Methods: We used the Registro Informatizado de Enfermedad Trombo Embólica (RIETE) registry to compare the outcomes during the course of anticoagulant therapy in patients with UEDVT versus outcomes in patients with LEDVT.
Results: As of August 2015, 37,366 patients with acute DVT had been enrolled in RIETE: 35094 (94%) had LEDVT, 1334 (3.
Nefrologia
December 2017
Servicio de Nefrología, Hospital Puerto Real, Cádiz, España.
J Thromb Haemost
July 2015
Department of Internal Medicine, Hospital Universitari Germans Trias i Pujol, Universidad Católica de Murcia, Murcia, Spain.
Background: No studies have identified which patients with upper-extremity deep vein thrombosis (DVT) are at low risk for adverse events within the first week of therapy.
Methods: We used data from Registro Informatizado de la Enfermedad TromboEmbólica to explore in patients with upper-extremity DVT a prognostic score that correctly identified patients with lower limb DVT at low risk for pulmonary embolism, major bleeding, or death within the first week.
Results: As of December 2014, 1135 outpatients with upper-extremity DVT were recruited.
Med Clin (Barc)
October 2011
Servicio de Nefrología, Fundació Privada Hospital de Mollet, Mollet del Vallés, Barcelona, Spain.
Background And Objective: Scleroderma renal crisis is a severe complication of systemic sclerosis, which causes arterial hypertension and acute renal failure. Early treatment of these patients with ACE inhibitors may improve prognosis. We aimed to analyze the frequency, clinical and epidemiological characteristics, morbidity and mortality and prognosis of scleroderma renal crisis.
View Article and Find Full Text PDFNefrologia
November 2009
Servicio de Nefrología, Fundacion privada Hospital de Mollet, Barcelona.
Cephalic arch stenosis (CAS) is a unique type of vascular access stenosis. For example, the etiology of CAS is under investigation and the prevalence of CAS can be lower in diabetic patients. Three cases of CAS were identified during our vascular access stenosis surveillance program by blood flow rate measurements using the Delta-H method.
View Article and Find Full Text PDFIntroduction: Vascular calcification is a common finding in patients (pts) with end-stage renal disease (ESRD).
Objective: The aim of this cross-sectional study was to investigate the prevalence and functional effect of native arteriovenous fistula AVF (feeding artery and/or arterialized vein) calcifications evaluated by spiral computed tomography (CT) in ESRD pts undergoing chronic hemodialysis (HD).
Patients And Method: Forty-five upper limb AVF (radial 44.
Nefrologia
January 2009
Servicio de Nefrología, Fundación Privada Hospital de Mollet, Barcelona.
Introduction: Periodic QA measurement is the preferred way for VA surveillance in end-stage renal disease (ESRD) patients (pts).
Objective: The aims of this study were to measure QA by TDT and to compare the functional results with Delta-H method.
Patients And Methods: We measured Q(A) non invasively in 38 VA (mean VA duration: 48.